Skip to content

Brainstimulation for emotion regulation in adolescents with psychiatric disorders – A clinical- transdiagnostical, randomized, triple-blind and sham-controlled neurotherapeutic trial

Brainstimulation for emotion regulation in adolescents with psychiatric disorders – A clinical- transdiagnostical, randomized, triple-blind and sham-controlled neurotherapeutic trial - Brainstimulation for emotion regulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025601
Enrollment
108
Registered
2021-06-28
Start date
2022-02-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transdiagnostic procedure includes exceeding the cut-off values ??on an emotion regulation questionnaire

Interventions

Group 1: Brainstimulation Group 2: Shamstimulation

Sponsors

Medizinische Universität WienUniversitätsklinik für Kinder- & Jugendpsychiatrie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 18 Years

Inclusion criteria

Inclusion criteria: (-) clinically relevant deficits in emotion regulation • Fulfillment of the primary diagnosis of a depressive disorder (F32, F33), a behavioral disorder (F91, F60.2) or an anxiety disorder (F40.1, F41.1) according to ICD 10 (106), • IQ> 70 (e.g. exclusion of severe, severe, moderate and mild intellectual disabilities), right-handers as well • informed consent of the participant and parents.

Exclusion criteria

Exclusion criteria: • all MRI contraindications such as non-removable metallic devices (cardiac pacemakers, defibrillator, cochlear implant, intracranial/cranial stimulators and other metals, any implant or stainless steel graft or any other contraindications for MRI) • epilepsy or related seizure disorders; • other severe neurologic, acute suicidality or medical conditions (in particular skull defect, craniotomy); • continuous antipsychotic and benzodiazepine medication*1;;

Design outcomes

Primary

MeasureTime frame
End point: Total score of the emotion regulation questionnaire (FEEL-KJ; 1; self-rating) at t2 (in the week after the intervention) [compared to the total score of the emotion regulation questionnaire (FEEL-KJ; 1) at t1 (in the week before the intervention) .] (1) FEEL-KJ: Grob A, Smolenski C. FEEL-KJ: Questionnaire for the assessment of emotion regulation in children and adolescents. (2009)

Secondary

MeasureTime frame
Changes in psychological disorders, affective and cogntive functions

Countries

Austria

Contacts

Public ContactLilian Konicar

Medizinische Universität WienUniversitätsklinik für Kinder- & Jugendpsychiatrie

lilian.konicar@meduniwien.ac.at0043 1 40 400 37460

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 12, 2026